During the past decade, Chesapeake Clinical Research, Inc conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 6 clinical trials were completed. i.e. 54.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chesapeake Clinical Research, Inc" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Aimmune Therapeutics, Inc." with 1 trials sponsored, "Allergy Therapeutics" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chesapeake Clinical Research, Inc" #1 collaborator was "Global BioClinical" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Chesapeake Clinical Research, Inc" are "Asthma" (3 trials), "Acute Respiratory Infection" (1 trials), "Asthma in Children" (1 trials), "Atopic Dermatitis" (1 trials) and "Chronic Rhinosinusitis" (1 trials). Many other conditions were trialed in "Chesapeake Clinical Research, Inc" in a lesser frequency.

Most popular intervention types in "Chesapeake Clinical Research, Inc" are "Drug" (10 trials), "Biological" (3 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "AR201 powder" (1 trials), "AS MDI" (1 trials), "Abrocitinib 100 mg" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chesapeake Clinical Research, Inc" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Chesapeake Clinical Research, Inc". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Chesapeake Clinical Research, Inc, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Chesapeake Clinical Research, Inc, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".